|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
The Future Role of Nuclear Fuel Cycle R&D in the UK
If you have a question about this talk, please contact Jo Boyle.
Nuclear is viewed by many as a mature, reliable low carbon technology with a secure and abundant fuel source and is an essential contributor to the energy mix. Within the UK the decision has been made to refresh the current nuclear energy plants to at least the replacement of the existing nuclear fleet. However it is also recognised that this may not be enough and as such expansion scenarios are being considered beyond the 16 GWe replacement up to 70 GW. As the UK decides on the level of Nuclear Energy required over the next century it is important to continue to be involved in advanced fuel cycle R&D to ensure: Maintenance of technical capability to keep the range of nuclear options open for various energy scenarios; UK is able to make informed decisions on future; UK energy policy and strategy; UK continues to be a credible player in Europe and Internationally; Best practice is realised through the opportunity to leverage investment through involvement in international programmes. Key R&D programme areas to ensure energy scenarios are adequately underpinned include: Fuel Cycle Stewardship; Fuel Manufacture and Performance; Recycle and Storage Technology; Reactor Systems; Waste Management and Disposal; Security and Safeguards.
This talk is part of the Engineering Department Nuclear Energy Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsCambridge Oncology Seminar Series Hearing Group Meetings DAMTP Fluids Talks
Other talksSelf-Organisation of Pluripotent Cells in the Mouse Embryo Plenary Lecture 5: Neutral models on island chains: biodiversity measures, and the 'everything is everywhere' problem. Manufacture of Low Cost Semiconductor Tunnelling Devices Histopathology 2014: Advances in research and techniques Using human genome variation to study history and cellular function Macrophage regulation of tumor responses to anticancer therapies